F&FFinancial Insights

Financial Metrics

PRA PROASSURANCE CORP
Range: 2016-01-01 to 2026-04-29
Chart Range:
% Change:

Financial Statements

Grouped by statement

Income Statement

Metrics: 6

Revenue

Q: 30 | A: 10

Quarterly

Annual

Show Data Rows
Frequency Period End Value % Chg Unit Form Filed
Quarterly 2016-03-31 193387000.0 USD 10-Q 2017-05-04
Quarterly 2016-06-30 214801000.0 +11.1% USD 10-Q 2017-08-07
Quarterly 2016-09-30 224352000.0 +4.4% USD 10-Q 2017-11-06
Quarterly 2017-03-31 222998000.0 -0.6% USD 10-Q 2018-05-03
Quarterly 2017-06-30 205577000.0 -7.8% USD 10-Q 2018-08-07
Quarterly 2017-09-30 228455000.0 +11.1% USD 10-Q 2018-11-06
Quarterly 2018-03-31 201032000.0 -12.0% USD 10-Q 2019-05-01
Quarterly 2018-06-30 256194000.0 +27.4% USD 10-Q 2019-08-07
Quarterly 2018-09-30 249325000.0 -2.7% USD 10-Q 2019-11-05
Quarterly 2019-03-31 268875000.0 +7.8% USD 10-Q 2020-05-07
Quarterly 2019-06-30 239621000.0 -10.9% USD 10-Q 2020-08-10
Quarterly 2019-09-30 241874000.0 +0.9% USD 10-Q 2020-11-05
Quarterly 2020-03-31 196701000.0 -18.7% USD 10-Q 2021-05-07
Quarterly 2020-06-30 221742000.0 +12.7% USD 10-Q 2021-08-09
Quarterly 2020-09-30 226897000.0 +2.3% USD 10-Q 2021-11-08
Quarterly 2021-03-31 220017000.0 -3.0% USD 10-Q 2022-05-09
Quarterly 2021-06-30 281628000.0 +28.0% USD 10-Q 2022-08-08
Quarterly 2021-09-30 309700000.0 +10.0% USD 10-Q 2022-11-08
Quarterly 2022-03-31 283072000.0 -8.6% USD 10-Q 2023-05-09
Quarterly 2022-06-30 255825000.0 -9.6% USD 10-Q 2023-08-08
Quarterly 2022-09-30 273083000.0 +6.7% USD 10-Q 2023-11-08
Quarterly 2023-03-31 272675000.0 -0.1% USD 10-Q 2024-05-06
Quarterly 2023-06-30 291831000.0 +7.0% USD 10-Q 2024-08-08
Quarterly 2023-09-30 275747000.0 -5.5% USD 10-Q 2024-11-07
Quarterly 2024-03-31 284697000.0 +3.2% USD 10-Q 2025-05-06
Quarterly 2024-06-30 290355000.0 +2.0% USD 10-Q 2025-08-05
Quarterly 2024-09-30 285253000.0 -1.8% USD 10-Q 2025-11-04
Quarterly 2025-03-31 272079000.0 -4.6% USD 10-Q 2025-05-06
Quarterly 2025-06-30 276753000.0 +1.7% USD 10-Q 2025-08-05
Quarterly 2025-09-30 279554000.0 +1.0% USD 10-Q 2025-11-04
Annual 2016-12-31 870214000.0 USD 10-K 2019-02-21
Annual 2017-12-31 866149000.0 -0.5% USD 10-K 2020-02-20
Annual 2018-12-31 886030000.0 +2.3% USD 10-K 2021-02-26
Annual 2019-12-31 999834000.0 +12.8% USD 10-K 2022-02-22
Annual 2020-12-31 874940000.0 -12.5% USD 10-K 2023-02-27
Annual 2021-12-31 1124410000.0 +28.5% USD 10-K 2024-02-27
Annual 2022-12-31 1106688000.0 -1.6% USD 10-K 2025-02-24
Annual 2023-12-31 1137212000.0 +2.8% USD 10-K 2026-02-23
Annual 2024-12-31 1150404000.0 +1.2% USD 10-K 2026-02-23
Annual 2025-12-31 1098028000.0 -4.6% USD 10-K 2026-02-23

Gross Profit

Q: 0 | A: 0

Quarterly

Annual

Show Data Rows
Frequency Period End Value % Chg Unit Form Filed

Operating Income

Q: 0 | A: 0

Quarterly

Annual

Show Data Rows
Frequency Period End Value % Chg Unit Form Filed

Net Income

Q: 30 | A: 10

Quarterly

Annual

Show Data Rows
Frequency Period End Value % Chg Unit Form Filed
Quarterly 2016-03-31 19317000.0 USD 10-Q 2017-05-04
Quarterly 2016-06-30 43081000.0 +123.0% USD 10-Q 2017-08-07
Quarterly 2016-09-30 33834000.0 -21.5% USD 10-Q 2017-11-06
Quarterly 2017-03-31 41455000.0 +22.5% USD 10-Q 2018-05-03
Quarterly 2017-06-30 19518000.0 -52.9% USD 10-Q 2018-08-07
Quarterly 2017-09-30 28949000.0 +48.3% USD 10-Q 2018-11-06
Quarterly 2018-03-31 11856000.0 -59.0% USD 10-Q 2019-05-01
Quarterly 2018-06-30 28423000.0 +139.7% USD 10-Q 2019-08-07
Quarterly 2018-09-30 31228000.0 +9.9% USD 10-Q 2019-11-05
Quarterly 2019-03-31 31650000.0 +1.4% USD 10-Q 2020-05-07
Quarterly 2019-06-30 11536000.0 -63.6% USD 10-Q 2020-08-10
Quarterly 2019-09-30 17193000.0 +49.0% USD 10-Q 2020-11-05
Quarterly 2020-03-31 -21954000.0 -227.7% USD 10-Q 2021-05-07
Quarterly 2020-06-30 -18099000.0 +17.6% USD 10-Q 2021-08-09
Quarterly 2020-09-30 -149979000.0 -728.7% USD 10-Q 2021-11-08
Quarterly 2021-03-31 7735000.0 +105.2% USD 10-Q 2022-05-09
Quarterly 2021-06-30 92050000.0 +1090.0% USD 10-Q 2022-08-08
Quarterly 2021-09-30 12200000.0 -86.7% USD 10-Q 2022-11-08
Quarterly 2022-03-31 -3560000.0 -129.2% USD 10-Q 2023-05-09
Quarterly 2022-06-30 -1659000.0 +53.4% USD 10-Q 2023-08-08
Quarterly 2022-09-30 -9125000.0 -450.0% USD 10-Q 2023-11-08
Quarterly 2023-03-31 -6174000.0 +32.3% USD 10-Q 2024-05-06
Quarterly 2023-06-30 10627000.0 +272.1% USD 10-Q 2024-08-08
Quarterly 2023-09-30 -49434000.0 -565.2% USD 10-Q 2024-11-07
Quarterly 2024-03-31 4626000.0 +109.4% USD 10-Q 2025-05-06
Quarterly 2024-06-30 15508000.0 +235.2% USD 10-Q 2025-08-05
Quarterly 2024-09-30 16441000.0 +6.0% USD 10-Q 2025-11-04
Quarterly 2025-03-31 -5822000.0 -135.4% USD 10-Q 2025-05-06
Quarterly 2025-06-30 21921000.0 +476.5% USD 10-Q 2025-08-05
Quarterly 2025-09-30 1446000.0 -93.4% USD 10-Q 2025-11-04
Annual 2016-12-31 151081000.0 USD 10-K 2019-02-21
Annual 2017-12-31 107264000.0 -29.0% USD 10-K 2020-02-20
Annual 2018-12-31 47057000.0 -56.1% USD 10-K 2021-02-26
Annual 2019-12-31 1004000.0 -97.9% USD 10-K 2022-02-22
Annual 2020-12-31 -175727000.0 -17602.7% USD 10-K 2023-02-27
Annual 2021-12-31 144124000.0 +182.0% USD 10-K 2024-02-27
Annual 2022-12-31 -402000.0 -100.3% USD 10-K 2025-02-24
Annual 2023-12-31 -38604000.0 -9503.0% USD 10-K 2026-02-23
Annual 2024-12-31 52744000.0 +236.6% USD 10-K 2026-02-23
Annual 2025-12-31 50915000.0 -3.5% USD 10-K 2026-02-23

EPS Basic

Q: 30 | A: 10

Quarterly

Annual

Show Data Rows
Frequency Period End Value % Chg Unit Form Filed
Quarterly 2016-03-31 0.36 USD/shares 10-Q 2017-05-04
Quarterly 2016-06-30 0.81 +125.0% USD/shares 10-Q 2017-08-07
Quarterly 2016-09-30 0.64 -21.0% USD/shares 10-Q 2017-11-06
Quarterly 2017-03-31 0.78 +21.9% USD/shares 10-Q 2018-05-03
Quarterly 2017-06-30 0.37 -52.6% USD/shares 10-Q 2018-08-07
Quarterly 2017-09-30 0.54 +45.9% USD/shares 10-Q 2018-11-06
Quarterly 2018-03-31 0.22 -59.3% USD/shares 10-Q 2019-05-01
Quarterly 2018-06-30 0.53 +140.9% USD/shares 10-Q 2019-08-07
Quarterly 2018-09-30 0.58 +9.4% USD/shares 10-Q 2019-11-05
Quarterly 2019-03-31 0.59 +1.7% USD/shares 10-Q 2020-05-07
Quarterly 2019-06-30 0.21 -64.4% USD/shares 10-Q 2020-08-10
Quarterly 2019-09-30 0.32 +52.4% USD/shares 10-Q 2020-11-05
Quarterly 2020-03-31 -0.41 -228.1% USD/shares 10-Q 2021-05-07
Quarterly 2020-06-30 -0.34 +17.1% USD/shares 10-Q 2021-08-09
Quarterly 2020-09-30 -2.78 -717.6% USD/shares 10-Q 2021-11-08
Quarterly 2021-03-31 0.14 +105.0% USD/shares 10-Q 2022-05-09
Quarterly 2021-06-30 1.71 +1121.4% USD/shares 10-Q 2022-08-08
Quarterly 2021-09-30 0.23 -86.5% USD/shares 10-Q 2022-11-08
Quarterly 2022-03-31 -0.07 -130.4% USD/shares 10-Q 2023-05-09
Quarterly 2022-06-30 -0.03 +57.1% USD/shares 10-Q 2023-08-08
Quarterly 2022-09-30 -0.17 -466.7% USD/shares 10-Q 2023-11-08
Quarterly 2023-03-31 -0.11 +35.3% USD/shares 10-Q 2024-05-06
Quarterly 2023-06-30 0.2 +281.8% USD/shares 10-Q 2024-08-08
Quarterly 2023-09-30 -0.95 -575.0% USD/shares 10-Q 2024-11-07
Quarterly 2024-03-31 0.09 +109.5% USD/shares 10-Q 2025-05-06
Quarterly 2024-06-30 0.3 +233.3% USD/shares 10-Q 2025-08-05
Quarterly 2024-09-30 0.32 +6.7% USD/shares 10-Q 2025-11-04
Quarterly 2025-03-31 -0.11 -134.4% USD/shares 10-Q 2025-05-06
Quarterly 2025-06-30 0.43 +490.9% USD/shares 10-Q 2025-08-05
Quarterly 2025-09-30 0.03 -93.0% USD/shares 10-Q 2025-11-04
Annual 2016-12-31 2.84 USD/shares 10-K 2019-02-21
Annual 2017-12-31 2.01 -29.2% USD/shares 10-K 2020-02-20
Annual 2018-12-31 0.88 -56.2% USD/shares 10-K 2021-02-26
Annual 2019-12-31 0.02 -97.7% USD/shares 10-K 2022-02-22
Annual 2020-12-31 -3.26 -16400.0% USD/shares 10-K 2023-02-27
Annual 2021-12-31 2.67 +181.9% USD/shares 10-K 2024-02-27
Annual 2022-12-31 -0.01 -100.4% USD/shares 10-K 2025-02-24
Annual 2023-12-31 -0.73 -7200.0% USD/shares 10-K 2026-02-23
Annual 2024-12-31 1.03 +241.1% USD/shares 10-K 2026-02-23
Annual 2025-12-31 0.99 -3.9% USD/shares 10-K 2026-02-23

EPS Diluted

Q: 30 | A: 10

Quarterly

Annual

Show Data Rows
Frequency Period End Value % Chg Unit Form Filed
Quarterly 2016-03-31 0.36 USD/shares 10-Q 2017-05-04
Quarterly 2016-06-30 0.81 +125.0% USD/shares 10-Q 2017-08-07
Quarterly 2016-09-30 0.63 -22.2% USD/shares 10-Q 2017-11-06
Quarterly 2017-03-31 0.77 +22.2% USD/shares 10-Q 2018-05-03
Quarterly 2017-06-30 0.36 -53.2% USD/shares 10-Q 2018-08-07
Quarterly 2017-09-30 0.54 +50.0% USD/shares 10-Q 2018-11-06
Quarterly 2018-03-31 0.22 -59.3% USD/shares 10-Q 2019-05-01
Quarterly 2018-06-30 0.53 +140.9% USD/shares 10-Q 2019-08-07
Quarterly 2018-09-30 0.58 +9.4% USD/shares 10-Q 2019-11-05
Quarterly 2019-03-31 0.59 +1.7% USD/shares 10-Q 2020-05-07
Quarterly 2019-06-30 0.21 -64.4% USD/shares 10-Q 2020-08-10
Quarterly 2019-09-30 0.32 +52.4% USD/shares 10-Q 2020-11-05
Quarterly 2020-03-31 -0.41 -228.1% USD/shares 10-Q 2021-05-07
Quarterly 2020-06-30 -0.34 +17.1% USD/shares 10-Q 2021-08-09
Quarterly 2020-09-30 -2.78 -717.6% USD/shares 10-Q 2021-11-08
Quarterly 2021-03-31 0.14 +105.0% USD/shares 10-Q 2022-05-09
Quarterly 2021-06-30 1.7 +1114.3% USD/shares 10-Q 2022-08-08
Quarterly 2021-09-30 0.23 -86.5% USD/shares 10-Q 2022-11-08
Quarterly 2022-03-31 -0.07 -130.4% USD/shares 10-Q 2023-05-09
Quarterly 2022-06-30 -0.03 +57.1% USD/shares 10-Q 2023-08-08
Quarterly 2022-09-30 -0.17 -466.7% USD/shares 10-Q 2023-11-08
Quarterly 2023-03-31 -0.11 +35.3% USD/shares 10-Q 2024-05-06
Quarterly 2023-06-30 0.2 +281.8% USD/shares 10-Q 2024-08-08
Quarterly 2023-09-30 -0.95 -575.0% USD/shares 10-Q 2024-11-07
Quarterly 2024-03-31 0.09 +109.5% USD/shares 10-Q 2025-05-06
Quarterly 2024-06-30 0.3 +233.3% USD/shares 10-Q 2025-08-05
Quarterly 2024-09-30 0.32 +6.7% USD/shares 10-Q 2025-11-04
Quarterly 2025-03-31 -0.11 -134.4% USD/shares 10-Q 2025-05-06
Quarterly 2025-06-30 0.42 +481.8% USD/shares 10-Q 2025-08-05
Quarterly 2025-09-30 0.03 -92.9% USD/shares 10-Q 2025-11-04
Annual 2016-12-31 2.83 USD/shares 10-K 2019-02-21
Annual 2017-12-31 2.0 -29.3% USD/shares 10-K 2020-02-20
Annual 2018-12-31 0.88 -56.0% USD/shares 10-K 2021-02-26
Annual 2019-12-31 0.02 -97.7% USD/shares 10-K 2022-02-22
Annual 2020-12-31 -3.26 -16400.0% USD/shares 10-K 2023-02-27
Annual 2021-12-31 2.67 +181.9% USD/shares 10-K 2024-02-27
Annual 2022-12-31 -0.01 -100.4% USD/shares 10-K 2025-02-24
Annual 2023-12-31 -0.73 -7200.0% USD/shares 10-K 2026-02-23
Annual 2024-12-31 1.03 +241.1% USD/shares 10-K 2026-02-23
Annual 2025-12-31 0.99 -3.9% USD/shares 10-K 2026-02-23

8-K Material Event Details

62 filings · 150 item records

This 8-K section tracks corporate event disclosures, not insider buy/sell sentiment. Insider trading direction is shown in the insider section below.

Event Type Distribution

Count per 8-K item

Insider Transaction History

140 transaction records

Net Insider Flow

Monthly open-market buy value minus open-market sell value

Monthly Insider Activity Mix

Share volume split between open-market trades, grants, and exercises

Transaction Value Timeline

Each circle = one priced transaction; size ∝ value

All Transactions

Date Insider Title Type Security Shares Price Total Value Post-Tx Shares
2026-02-25 Dishart Noreen Executive VP/Chief HR Officer Exercise / conversion
M · derivative
Restricted Share Units 3,101 $0.00 $0 0
2026-02-25 Dishart Noreen Executive VP/Chief HR Officer Exercise / conversion
M · derivative
Restricted Stock Units 5,987 $0.00 $0 0
2026-02-25 Dishart Noreen Executive VP/Chief HR Officer Exercise / conversion
M · derivative
Restricted Stock Unit 4,588 $0.00 $0 0
2026-02-25 Dishart Noreen Executive VP/Chief HR Officer Other disposed transaction
F
Common Stock 5,917 $24.47 $144,789 27,740
2026-02-25 Dishart Noreen Executive VP/Chief HR Officer Exercise / conversion
M
Common Stock 4,588 $24.47 $112,268 33,657
2026-02-25 Dishart Noreen Executive VP/Chief HR Officer Exercise / conversion
M
Common Stock 5,987 $24.47 $146,502 29,069
2026-02-25 Dishart Noreen Executive VP/Chief HR Officer Exercise / conversion
M
Common Stock 3,101 $24.47 $75,881 23,082
2026-01-07 Lisenby Jeffrey Patton Executive Vice-President Equity grant / award
A · derivative
Restricted Stock Units 23,720 $0.00 $0 23,720
2025-05-23 Rand Edward Lewis Jr President & CEO Exercise / conversion
M · derivative
Restricted Stock Units 29,666 $0.00 $0 0
2025-05-23 Rand Edward Lewis Jr President & CEO Other disposed transaction
F
Common Stock 12,564 $23.15 $290,857 252,516
2025-05-23 Rand Edward Lewis Jr President & CEO Exercise / conversion
M
Common Stock 29,666 $23.15 $686,768 265,080
2025-05-21 COBARRUBIAS FABILOA Dir Equity grant / award
A
Common Stock 4,101 $23.16 $94,979 25,184
2025-02-25 Dishart Noreen Executive VP/Chief HR Officer Exercise / conversion
M · derivative
Restricted Stock Units 3,100 $0.00 $0 0
2025-02-25 Dishart Noreen Executive VP/Chief HR Officer Exercise / conversion
M · derivative
Restricted Stock Units 7,065 $0.00 $0 0
2025-02-25 Dishart Noreen Executive VP/Chief HR Officer Equity grant / award
A · derivative
Restricted Stock Unit 13,763 $0.00 $0 13,763
2025-02-25 Dishart Noreen Executive VP/Chief HR Officer Other disposed transaction
F
Common Stock 3,888 $16.13 $62,713 16,479
2025-02-25 Dishart Noreen Executive VP/Chief HR Officer Exercise / conversion
M
Common Stock 3,100 $16.13 $50,003 20,367
2025-02-25 Dishart Noreen Executive VP/Chief HR Officer Exercise / conversion
M
Common Stock 7,065 $16.13 $113,958 17,267
2024-07-01 Rand Edward Lewis Jr President & CEO Exercise / conversion
M · derivative
Restricted Stock Unit 55,157 $0.00 $0 0
2024-07-01 Rand Edward Lewis Jr President & CEO Other disposed transaction
F
Common Stock 23,066 $12.20 $281,405 201,513
2024-07-01 Rand Edward Lewis Jr President & CEO Exercise / conversion
M
Common Stock 55,157 $12.20 $672,915 224,579
2024-05-23 COBARRUBIAS FABILOA Dir Equity grant / award
A
Common Stock 13,988 $14.57 $203,805 21,083
2024-05-22 Shook Kevin Merrick President of a Subsidiary Equity grant / award
A · derivative
Restricted Share Units 23,058 $0.00 $0 23,058
2024-03-06 FRANCIS ROBERT DAVID Pres Healthcare Pro. Liability Exercise / conversion
M · derivative
Restricted Stock Units 7,111 $0.00 $0 0
2024-03-06 FRANCIS ROBERT DAVID Pres Healthcare Pro. Liability Exercise / conversion
M · derivative
Restricted Stock Units 3,226 $0.00 $0 0
2024-03-06 FRANCIS ROBERT DAVID Pres Healthcare Pro. Liability Other disposed transaction
F
Common Stock 4,383 $12.36 $54,174 9,623
2024-03-06 FRANCIS ROBERT DAVID Pres Healthcare Pro. Liability Exercise / conversion
M
Common Stock 3,226 $12.36 $39,873 14,006
2024-03-06 FRANCIS ROBERT DAVID Pres Healthcare Pro. Liability Exercise / conversion
M
Common Stock 7,111 $12.36 $87,892 10,780
2023-05-24 Wilson Thomas A.S. Jr Dir Equity grant / award
A
Common Stock 7,468 $12.72 $94,993 34,477
2023-05-24 Angiolillo Bruce D Dir Other disposed transaction
J
Common Stock 0 17,563
2023-04-13 Wilson Thomas A.S. Jr Dir Equity grant / award
A
Common Stock 68 $18.44 $1,254 27,009
2023-03-10 HENDRICKS DANA S Chief Financial Officer Other disposed transaction
F
Common Stock 2,198 $19.89 $43,718 17,870
2023-03-10 HENDRICKS DANA S Chief Financial Officer Equity grant / award
A
Common Stock 7,541 $19.89 $149,990 20,068
2023-03-08 Boguski Michael Leonard President of a Subsidiary Exercise / conversion
M · derivative
Restricted Stock Units 6,498 $0.00 $0 0
2023-03-08 Boguski Michael Leonard President of a Subsidiary Other disposed transaction
F
Common Stock 2,800 $19.89 $55,692 55,932
2023-03-08 Boguski Michael Leonard President of a Subsidiary Exercise / conversion
M
Common Stock 6,498 $19.89 $129,245 58,732
2023-01-10 Wilson Thomas A.S. Jr Dir Equity grant / award
A
Common Stock 70 $17.93 $1,255 26,941
2022-10-13 Wilson Thomas A.S. Jr Dir Equity grant / award
A
Common Stock 62 $20.21 $1,253 26,871
2022-06-29 Wilson Thomas A.S. Jr Dir Equity grant / award
A
Common Stock 54 $23.12 $1,248 26,809
2022-05-24 Wilson Thomas A.S. Jr Dir Equity grant / award
A
Common Stock 4,447 $21.36 $94,988 26,755
2022-04-07 Wilson Thomas A.S. Jr Dir Equity grant / award
A
Common Stock 39 $26.26 $1,024 22,308
2022-03-11 HENDRICKS DANA S Chief Financial Officer Other disposed transaction
F
Common Stock 1,245 $24.77 $30,839 10,511
2022-03-11 HENDRICKS DANA S Chief Financial Officer Exercise / conversion
M
Common Stock 4,273 $24.77 $105,842 11,756
2022-03-02 Shook Kevin Merrick President of a Subsidiary Exercise / conversion
M · derivative
Restricted Share Units 5,434 $0.00 $0 0
2022-03-02 Shook Kevin Merrick President of a Subsidiary Equity grant / award
A · derivative
Restricted Stock Units 9,084 $0.00 $0 9,084
2022-03-02 Shook Kevin Merrick President of a Subsidiary Other disposed transaction
F
Common Stock 2,444 $24.77 $60,538 21,673
2022-03-02 Shook Kevin Merrick President of a Subsidiary Exercise / conversion
M
Common Stock 5,434 $24.77 $134,600 24,117
2022-01-07 Wilson Thomas A.S. Jr Dir Equity grant / award
A
Common Stock 40 $25.41 $1,016 22,269
2021-10-08 Wilson Thomas A.S. Jr Dir Equity grant / award
A
Common Stock 45 $22.75 $1,024 22,229
2021-07-14 Wilson Thomas A.S. Jr Dir Equity grant / award
A
Common Stock 48 $21.21 $1,018 22,184
2021-05-25 Angiolillo Bruce D Dir Equity grant / award
A
Common Stock 2,555 $23.87 $60,988 12,830
2021-04-13 Wilson Thomas A.S. Jr Dir Equity grant / award
A
Common Stock 33 $26.87 $887 19,581
2021-03-08 Shook Kevin Merrick President of a Subsidiary Other disposed transaction
F
Common Stock 889 $24.61 $21,878 18,683
2021-03-08 Shook Kevin Merrick President of a Subsidiary Exercise / conversion
M
Common Stock 3,125 $24.61 $76,906 19,572
2021-03-03 Shook Kevin Merrick President of a Subsidiary Exercise / conversion
M · derivative
Restricted Stock Units 2,590 $0.00 $0 0
2021-03-03 Shook Kevin Merrick President of a Subsidiary Equity grant / award
A · derivative
Restricted Share Units $0.00 8,126
2021-03-03 Shook Kevin Merrick President of a Subsidiary Other disposed transaction
F
Common Stock 1,228 $24.61 $30,221 16,447
2021-03-03 Shook Kevin Merrick President of a Subsidiary Exercise / conversion
M
Common Stock 2,590 $24.61 $63,740 17,675
2021-01-07 Wilson Thomas A.S. Jr Dir Equity grant / award
A
Common Stock 45 $19.69 $886 19,548
2020-10-09 Wilson Thomas A.S. Jr Dir Equity grant / award
A
Common Stock 55 $16.16 $889 19,503
2020-07-08 Wilson Thomas A.S. Jr Dir Equity grant / award
A
Common Stock 64 $13.64 $873 19,448
2020-05-20 Wilson Thomas A.S. Jr Dir Equity grant / award
A
Common Stock 4,292 $14.21 $60,989 19,384
2020-05-13 Spinosa Frank Anthony Dir Open-market buy
P
Common Stock 339 $14.47 $4,905 12,315
2020-04-15 Wilson Thomas A.S. Jr Dir Equity grant / award
A
Common Stock 211 $19.30 $4,072 15,092
2020-03-04 Shook Kevin Merrick President of a Subsidiary Exercise / conversion
M · derivative
Restricted Stock Units 1,600 $0.00 $0 0
2020-03-04 Shook Kevin Merrick President of a Subsidiary Equity grant / award
A · derivative
Restricted Share Units 6,116 $0.00 $0 6,116
2020-03-04 Shook Kevin Merrick President of a Subsidiary Other disposed transaction
F
Common Stock 759 $32.70 $24,819 15,085
2020-03-04 Shook Kevin Merrick President of a Subsidiary Exercise / conversion
M
Common Stock 1,600 $32.70 $52,320 15,844
2020-01-14 Wilson Thomas A.S. Jr Dir Equity grant / award
A
Common Stock 112 $35.79 $4,008 14,881
2019-10-11 Wilson Thomas A.S. Jr Dir Equity grant / award
A
Common Stock 101 $39.65 $4,005 14,769
2019-10-03 Wilson Thomas A.S. Jr Dir Exercise / conversion
M · derivative
Restricted Stock Units 93 0
2019-10-03 Wilson Thomas A.S. Jr Dir Exercise / conversion
M · derivative
Restricted Stock Units 90 0
2019-10-03 Wilson Thomas A.S. Jr Dir Exercise / conversion
M
Common Stock 90 $38.72 $3,485 14,668
2019-10-03 Wilson Thomas A.S. Jr Dir Exercise / conversion
M
Common Stock 93 $38.72 $3,601 14,578
2019-07-11 Wilson Thomas A.S. Jr Dir Equity grant / award
A
Common Stock 100 $39.58 $3,958 14,485
2019-06-25 MCMAHON JOHN J JR Dir Open-market sell
S
Common Stock 933 $36.19 $33,765 0
2019-05-22 Wilson Thomas A.S. Jr Dir Equity grant / award
A
Common Stock 1,578 $38.65 $60,990 14,385
2019-04-22 Wilson Thomas A.S. Jr Dir Equity grant / award
A
Common Stock 98 $35.02 $3,432 12,807
2019-02-22 Taubman Ross Edward Presdent of a Subsidiary Exercise / conversion
M · derivative
Restricted Stock Units 2,000 $0.00 $0 0
2019-02-22 Taubman Ross Edward Presdent of a Subsidiary Equity grant / award
A · derivative
Restricted Stock Units 4,576 $0.00 $0 4,576
2019-02-22 Taubman Ross Edward Presdent of a Subsidiary Equity grant / award
A
Common Stock 2,819 $43.70 $123,190 37,960
2019-02-22 Taubman Ross Edward Presdent of a Subsidiary Other disposed transaction
F
Common Stock 564 $43.70 $24,647 35,141
2019-02-22 Taubman Ross Edward Presdent of a Subsidiary Exercise / conversion
M
Common Stock 2,000 $43.70 $87,400 35,705
2019-02-22 Taubman Ross Edward Presdent of a Subsidiary Exercise / conversion
M · derivative
Restricted Stock Units 2,000 $0.00 $0 0
2019-02-22 Taubman Ross Edward Presdent of a Subsidiary Equity grant / award
A · derivative
Restricted Stock Units 4,576 $0.00 $0 4,576
2019-02-22 Taubman Ross Edward Presdent of a Subsidiary Equity grant / award
A
Common Stock 2,289 $43.70 $100,029 37,194
2019-02-22 Taubman Ross Edward Presdent of a Subsidiary Other disposed transaction
F
Common Stock 800 $43.70 $34,960 34,905
2019-02-22 Taubman Ross Edward Presdent of a Subsidiary Exercise / conversion
M
Common Stock 2,000 $43.70 $87,400 35,705
2019-01-09 Wilson Thomas A.S. Jr Dir Equity grant / award
A
Common Stock 217 $40.72 $8,836 12,709
2018-10-10 Wilson Thomas A.S. Jr Dir Equity grant / award
A
Common Stock 73 $25.60 $1,869 12,492
2018-10-05 HENDRICKS DANA S Chief Financial Officer Exercise / conversion
M · derivative
Common Stock 100 0
2018-10-05 HENDRICKS DANA S Chief Financial Officer Exercise / conversion
M
Common Stock 70 $45.62 $3,193 3,372
2018-10-05 Wilson Thomas A.S. Jr Dir Exercise / conversion
M · derivative
Restricted Stock Units 100 0
2018-10-05 Wilson Thomas A.S. Jr Dir Exercise / conversion
M
Common Stock 100 $45.62 $4,562 12,419
2018-07-10 Wilson Thomas A.S. Jr Dir Equity grant / award
A
Common Stock 88 $37.05 $3,260 12,319
2018-06-13 Gorrie Magnus James Dir Open-market buy
P
Common Stock 2,000 $39.20 $78,400 14,231
2018-05-23 Wilson Thomas A.S. Jr Dir Equity grant / award
A
Common Stock 1,511 $40.35 $60,969 12,231
2018-05-08 O NEIL FRANK B Senior Vice-President Open-market buy
P
Common Stock 3,000 $40.75 $122,250 108,363
2018-05-07 FRIEDMAN HOWARD H President, HCPL Group Open-market buy
P
Common Stock 2,000 $40.75 $81,500 273,153
2018-04-18 Wilson Thomas A.S. Jr Dir Equity grant / award
A
Common Stock 61 $47.15 $2,876 10,720
2018-03-09 O NEIL FRANK B Senior Vice-President Equity grant / award
G
Common Stock 3,000 $0.00 $0 106,363
2018-02-22 Taubman Ross Edward Presdent of a Subsidiary Exercise / conversion
M · derivative
Restricted Stock Units 2,550 $0.00 $0 0
2018-02-22 Taubman Ross Edward Presdent of a Subsidiary Equity grant / award
A · derivative
Restricted Stock Units 3,886 $0.00 $0 3,886
2018-02-22 Taubman Ross Edward Presdent of a Subsidiary Other disposed transaction
F
Common Stock 1,020 $48.25 $49,215 33,630
2018-02-22 Taubman Ross Edward Presdent of a Subsidiary Exercise / conversion
M
Common Stock 2,550 $48.25 $123,038 34,650
2018-02-22 Taubman Ross Edward Presdent of a Subsidiary Exercise / conversion
M
Common Stock 3,825 $48.25 $184,556 32,100
2018-01-17 STARNES WILLIAM STANCIL Chairman Open-market sell
S
Common Stock 89,699 $55.18 $4,949,322 177,337
2018-01-16 STARNES WILLIAM STANCIL Chairman Open-market sell
S
Common Stock 10,736 $55.00 $590,480 267,036
2018-01-12 STARNES WILLIAM STANCIL Chairman Open-market sell
S
Common Stock 25,896 $55.01 $1,424,539 277,772
2018-01-10 Wilson Thomas A.S. Jr Dir Equity grant / award
A
Common Stock 767 $54.65 $41,917 10,659
2017-10-10 Wilson Thomas A.S. Jr Dir Equity grant / award
A
Common Stock 47 $55.50 $2,608 9,892
2017-10-05 Wilson Thomas A.S. Jr Dir Exercise / conversion
M · derivative
Restricted Stock Units 112 0
2017-10-05 Wilson Thomas A.S. Jr Dir Equity grant / award
A · derivative
Restricted Stock Units 90 $0.00 $0 90
2017-10-05 Wilson Thomas A.S. Jr Dir Exercise / conversion
M
Common Stock 112 $0.00 $0 9,845
2017-10-05 Wilson Thomas A.S. Jr Dir Equity grant / award
A
Common Stock 90 $55.35 $4,982 9,733
2017-08-18 O NEIL FRANK B Senior Vice-President Open-market buy
P
Common Stock 2,500 $54.50 $136,250 104,431
2017-08-11 O NEIL FRANK B Senior Vice-President Open-market buy
P
Common Stock 2,500 $54.75 $136,875 101,931
2017-08-09 FRIEDMAN HOWARD H President, HCPL Group Open-market buy
P
Common Stock 2,000 $55.00 $110,000 259,573
2017-07-12 Wilson Thomas A.S. Jr Dir Equity grant / award
A
Common Stock 42 $61.10 $2,566 9,643
2017-07-07 Lisenby Jeffrey Patton Executive Vice-President Open-market sell
S
Common Stock 6,171 $61.57 $379,948 44,238
2017-07-05 Lisenby Jeffrey Patton Executive Vice-President Open-market sell
S
Common Stock 427 $61.50 $26,260 50,409
2017-07-03 Lisenby Jeffrey Patton Executive Vice-President Open-market sell
S
Common Stock 4,402 $61.61 $271,207 50,836
2017-06-28 Rand Edward Lewis Jr Chief Financial Officer Open-market sell
S
Common Stock 13,745 $60.41 $830,335 103,334
2017-06-27 Rand Edward Lewis Jr Chief Financial Officer Open-market sell
S
Common Stock 100 $60.00 $6,000 117,079
2017-06-26 Rand Edward Lewis Jr Chief Financial Officer Open-market sell
S
Common Stock 2,835 $60.12 $170,440 117,179
2017-06-23 Rand Edward Lewis Jr Chief Financial Officer Open-market sell
S
Common Stock 320 $60.00 $19,200 120,014
2017-05-31 Wilson Thomas A.S. Jr Dir Equity grant / award
A
Common Stock 666 $59.55 $39,660 9,601
2017-05-31 Wilson Thomas A.S. Jr Dir Equity grant / award
A
Common Stock 940 $59.55 $55,977 8,935
2017-02-23 BREWER KELLY BOUNDS Chief Accounting Officer Exercise / conversion
M · derivative
Restricted Share Units 1,000 $0.00 $0 1,275
2017-02-23 BREWER KELLY BOUNDS Chief Accounting Officer Equity grant / award
A · derivative
Restricted Share Units 1,275 $0.00 $0 2,275
2017-02-23 BREWER KELLY BOUNDS Chief Accounting Officer Exercise / conversion
M
Common Stock 600 $61.85 $37,110 8,263
2017-02-23 BREWER KELLY BOUNDS Chief Accounting Officer Exercise / conversion
M
Common Stock 700 $61.85 $43,295 7,663
2017-01-03 Boguski Michael Leonard President of a Subsidiary Equity grant / award
A
Common Stock 2,678 $56.00 $149,968 16,111
2016-12-13 Rand Edward Lewis Jr Chief Financial Officer Equity grant / award
G
Common Stock 1,650 $0.00 $0 109,331
2016-10-10 Boguski Michael Leonard President of a Subsidiary Equity grant / award
L
Common Stock 75 $54.42 $4,081 13,433
2016-10-05 Wilson Thomas A.S. Jr Dir Equity grant / award
A · derivative
Restricted Stock Units 93 $0.00 $0 93
2016-10-05 Wilson Thomas A.S. Jr Dir Equity grant / award
A
Common Stock 93 $51.29 $4,770 7,995
2016-07-11 Boguski Michael Leonard President of a Subsidiary Equity grant / award
L
Common Stock 78 $51.81 $4,041 13,358
2016-05-25 Wilson Thomas A.S. Jr Dir Equity grant / award
A
Common Stock 235 $51.29 $12,053 7,902
2016-05-25 Wilson Thomas A.S. Jr Dir Equity grant / award
A
Common Stock 1,091 $51.29 $55,957 7,667

Regulatory Activity

Last 12 months to 2025-04-29
Insider Filings (Forms 3/4/5) — 12 months
4
Material Event Filings (8-K) — 12 months
8

8-K Material Event Filing Activity

Monthly count

Insider Trading Activity (Forms 3/4/5)

Monthly count
For informational purposes only — not guaranteed to be accurate or complete.